Physician profile
Whitney Call
NPI 1740522515
$2,808.87
in general payments reported to CMS, 2019-2025
17 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $125 · 2021: $261 · 2022: $316 · 2023: $313 · 2024: $1,115 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,779 · Education: $32.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,779.05 |
| Education | $32.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $683.30 | 2021-2024 | Libtayo, Dupixent |
| Abbvie INC. | $411.28 | 2021-2025 | Rinvoq |
| E.R. Squibb & Sons, L.L.C. | $270.82 | 2023-2024 | Sotyktu |
| Ucb, INC. | $254.97 | 2020-2024 | Bimzelx |
| Lilly USA, LLC | $234.50 | 2021-2025 | Ebglyss, Taltz |
| Genzyme Corporation | $231.36 | 2021-2025 | |
| Amgen INC. | $137.44 | 2021-2023 | Otezla, Enbrel |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Allergan, INC. | $121.10 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $99.03 | 2021-2023 | Ilumya |
| Celgene Corporation | $86.46 | 2019-2024 | Reblozyl |
| Biofrontera INC. | $58.11 | 2022-2025 | Bf-Rhodoled, Ameluz, Rhodoled Xl |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.10 | 2022 | |
| Arcutis Biotherapeutics, INC. | $19.17 | 2023 | |
| Dermavant Sciences, INC. | $17.58 | 2024 | Vtama |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $16.96 | 2022 | |
| Galderma Laboratories, L.P. | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Call listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.